ES2044561T3 - Composiciones liquidas administrables por via oral a base de aceites comestibles. - Google Patents

Composiciones liquidas administrables por via oral a base de aceites comestibles.

Info

Publication number
ES2044561T3
ES2044561T3 ES90902945T ES90902945T ES2044561T3 ES 2044561 T3 ES2044561 T3 ES 2044561T3 ES 90902945 T ES90902945 T ES 90902945T ES 90902945 T ES90902945 T ES 90902945T ES 2044561 T3 ES2044561 T3 ES 2044561T3
Authority
ES
Spain
Prior art keywords
originally
liquid compositions
compositions based
edible oils
administrable liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902945T
Other languages
English (en)
Inventor
Leonard Chavkin
Leonard Mackles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2044561T3 publication Critical patent/ES2044561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTAN COMPUESTOS LIQUIDOS ORALMENTE ADMINISTRABLES PARA SUSPENDER EN LOS MISMOS COMPUESTOS FARMACOLOGICAMENTE ACTIVOS Y ORALMENTE ADMINISTRABLES QUE COMPRENDEN TRIGLICERIDOS, ESTERGLICOL DE PROPILENO O GLICERIDOS MONOACETILADOS DE ACIDOS ALCANOICOS DE LONGITUD MEDIA DE CADENA , ESTERES DE POLIGLICEROL, Y DIOXIDO DE SILICIO COLOIDAL.
ES90902945T 1989-01-03 1990-01-02 Composiciones liquidas administrables por via oral a base de aceites comestibles. Expired - Lifetime ES2044561T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/293,194 US4980175A (en) 1989-01-03 1989-01-03 Liquid orally administrable compositions based on edible oils

Publications (1)

Publication Number Publication Date
ES2044561T3 true ES2044561T3 (es) 1994-01-01

Family

ID=23128090

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902945T Expired - Lifetime ES2044561T3 (es) 1989-01-03 1990-01-02 Composiciones liquidas administrables por via oral a base de aceites comestibles.

Country Status (8)

Country Link
US (1) US4980175A (es)
EP (1) EP0452416B1 (es)
JP (1) JPH04502623A (es)
AU (1) AU5045490A (es)
CA (1) CA2045488A1 (es)
DE (1) DE69002611T2 (es)
ES (1) ES2044561T3 (es)
WO (1) WO1990007343A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
CH682131A5 (es) * 1991-04-25 1993-07-30 Applied Pharma Res
US5164379A (en) * 1991-07-15 1992-11-17 Bristol-Myers Company Sucralfate/cyclodextrin complexes
DE9212938U1 (es) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim, De
US5484800A (en) * 1994-08-30 1996-01-16 American Home Products Corporation Lipid-based liquid medicinal composition
US5853787A (en) * 1995-12-22 1998-12-29 Tamer International Method for reducing coffee acidity
US6066342A (en) * 1995-12-22 2000-05-23 Tamer International, Ltd. Antacid composition
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
WO2012020279A1 (en) * 2010-08-13 2012-02-16 Compagnie Gervais Danone Product for the upper gastric sphere
MX2014001556A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Composicion farmaceutica de sabor enmascarado.
US10828311B2 (en) 2012-02-27 2020-11-10 Bayer New Zealand Limited Controlled release compositions and their methods of use
US10245284B2 (en) * 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL261496A (es) * 1960-02-26
US2988483A (en) * 1960-10-19 1961-06-13 Drew & Co Inc E F Alchol soluble glycerides
GB1269987A (en) * 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
GB1547164A (en) * 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4889709A (en) * 1985-03-18 1989-12-26 Product Resources International, Inc. Aerosol foam with adsorbate and container containing same
US4752465A (en) * 1985-09-20 1988-06-21 Product Resources International, Inc. Aerosol foam
US4639367A (en) * 1985-03-18 1987-01-27 Product Resources International, Inc. Aerosol foam
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
JPS62186936A (ja) * 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物

Also Published As

Publication number Publication date
DE69002611D1 (de) 1993-09-09
US4980175A (en) 1990-12-25
CA2045488A1 (en) 1990-07-04
EP0452416B1 (en) 1993-08-04
JPH04502623A (ja) 1992-05-14
WO1990007343A1 (en) 1990-07-12
DE69002611T2 (de) 1994-02-03
AU5045490A (en) 1990-08-01
EP0452416A1 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
ES2044561T3 (es) Composiciones liquidas administrables por via oral a base de aceites comestibles.
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
ES2016585B3 (es) Polibutilaminas y poliisobutilaminas, procedimiento para su preparacion y composiciones combustibles y lubricantes que contienen estas sustancias.
PT83872A (de) Arzneimittel
DE60020552D1 (de) Arzneimittelträger
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ES2168271T3 (es) Composiciones farmaceuticas que contienen ciclosporinas.
AR008630A1 (es) Indol-3-glioxilamidas n-sustituidas con efecto antiasmatico, antialergico e inmunosupresor/inmunomodulador, procedimientos para su preparacion, suutilizacion farmaceutica y las composiciones farmaceuticas que las contienen.
DE3866645D1 (de) Dispergierzusatzgemisch fuer oelzusammensetzungen.
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
DE3763582D1 (de) Diltiazem und einen inhibitor des umwandlungsenzyms des angiotensins enthaltende arzneimittel.
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
UY24248A1 (es) Composiciones farmacéuticas que contienen inhibidores de proteinasa
MX6424A (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen.
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
FI874450A0 (fi) Farmaceutiska sammansaettningar vid terapin av hjaernsjukdomar pao funktionell och organisk bas.
SE8003850L (sv) Plasmaexpanderande medel
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
ATE228556T1 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung
ES2031922T3 (es) Composiciones terapeuticas estables a base de aceite vegetal hidrofobo y su procedimiento de preparacion.
RU98116473A (ru) Применение ингибиторов натрий-водородного обмена для получения лекарственного средства в целях уменьшения нежелательных воздействий веществ на сердце
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.
DE59002150D1 (de) Orale zubereitungsform des oestradiolvalerats.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 452416

Country of ref document: ES